{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:00:11Z","timestamp":1790265611772,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,10,24]],"date-time":"2013-10-24T00:00:00Z","timestamp":1382572800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s11096-013-9867-8","type":"journal-article","created":{"date-parts":[[2013,10,23]],"date-time":"2013-10-23T12:27:04Z","timestamp":1382531224000},"page":"120-127","source":"Crossref","is-referenced-by-count":30,"title":["Disease acceptance and adherence to imatinib in Taiwanese chronic myeloid leukaemia outpatients"],"prefix":"10.1007","volume":"36","author":[{"given":"Li-Chia","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng-Chou","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaw-Bin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Sung","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,24]]},"reference":[{"key":"9867_CR1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1547-5069.2003.tb00001.x","volume":"35","author":"PV Burkhart","year":"2003","unstructured":"Burkhart PV, Sabate E. Adherence to long-term therapies: evidence for action. J Nurs Scholarsh. 2003;35:207.","journal-title":"J Nurs Scholarsh"},{"key":"9867_CR2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.38875.675486.55","volume":"333","author":"SH Simpson","year":"2006","unstructured":"Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333:15.","journal-title":"BMJ"},{"key":"9867_CR3","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/01.mlr.0000163641.86870.af","volume":"43","author":"MC Sokol","year":"2005","unstructured":"Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43:521\u201330.","journal-title":"Med Care"},{"key":"9867_CR4","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1592\/phco.28.4.437","volume":"28","author":"BA Briesacher","year":"2008","unstructured":"Briesacher BA, Andrade SE, Fouayzi H, Chan KA. Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy. 2008;28:437\u201343.","journal-title":"Pharmacotherapy"},{"key":"9867_CR5","doi-asserted-by":"crossref","first-page":"728","DOI":"10.18553\/jmcp.2009.15.9.728","volume":"15","author":"J Yeaw","year":"2009","unstructured":"Yeaw J, Benner JS, Walt JG, Sian S, Smith DB. Comparing adherence and persistence across 6 chronic medication classes. J Manag Care Pharm. 2009;15:728\u201340.","journal-title":"J Manag Care Pharm"},{"issue":"Suppl 1","key":"9867_CR6","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/S0895-4356(01)00457-7","volume":"54","author":"J Dunbar-Jacob","year":"2001","unstructured":"Dunbar-Jacob J, Mortimer-Stephens MK. Treatment adherence in chronic disease. J Clin Epidemiol. 2001;54(Suppl 1):S57\u201360.","journal-title":"J Clin Epidemiol"},{"key":"9867_CR7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2710.2001.00363.x","volume":"26","author":"E Vermeire","year":"2001","unstructured":"Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther. 2001;26:331\u201342.","journal-title":"J Clin Pharm Ther"},{"key":"9867_CR8","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1742-1241.2007.01630.x","volume":"62","author":"JA Cramer","year":"2008","unstructured":"Cramer JA, Benedict A, Muszbek N, Keskinaslan A, Khan ZM. The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review. Int J Clin Pract. 2008;62:76\u201387.","journal-title":"Int J Clin Pract"},{"key":"9867_CR9","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/00005650-200209000-00009","volume":"40","author":"MR DiMatteo","year":"2002","unstructured":"DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40:794\u2013811.","journal-title":"Med Care"},{"key":"9867_CR10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1524-4733.2007.00213.x","volume":"11","author":"JA Cramer","year":"2008","unstructured":"Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11:44\u20137.","journal-title":"Value Health"},{"key":"9867_CR11","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0959-8049(01)00371-9","volume":"38","author":"MM Borner","year":"2002","unstructured":"Borner MM, Schoffski P, de Wit R, Caponigro F, Comella G, Sulkes A, et al. Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer. Eur J Cancer. 2002;38:349\u201358.","journal-title":"Eur J Cancer"},{"key":"9867_CR12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1200\/JCO.1997.15.1.110","volume":"15","author":"G Liu","year":"1997","unstructured":"Liu G, Franssen E, Fitch MI, Warner E. Patient preferences for oral versus intravenous palliative chemotherapy. J Clin Oncol. 1997;15:110\u20135.","journal-title":"J Clin Oncol"},{"key":"9867_CR13","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1200\/JCO.2006.08.8617","volume":"25","author":"AS Coates","year":"2007","unstructured":"Coates AS, Keshaviah A, Thurlimann B, Mouridsen H, Mauriac L, Forbes JF, et al. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98. J Clin Oncol. 2007;25:486\u201392.","journal-title":"J Clin Oncol"},{"key":"9867_CR14","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1200\/JCO.2009.25.9655","volume":"28","author":"DL Hershman","year":"2010","unstructured":"Hershman DL, Kushi LH, Shao T, Buono D, Kershenbaum A, Tsai WY, et al. Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol. 2010;28:4120\u20138.","journal-title":"J Clin Oncol"},{"key":"9867_CR15","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1200\/JCO.2009.26.4671","volume":"28","author":"AH Partridge","year":"2010","unstructured":"Partridge AH, Archer L, Kornblith AB, Gralow J, Grenier D, Perez E, et al. Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104. J Clin Oncol. 2010;28:2418\u201322.","journal-title":"J Clin Oncol"},{"key":"9867_CR16","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/01.mlr.0000114908.90348.f9","volume":"42","author":"MR DiMatteo","year":"2004","unstructured":"DiMatteo MR. Variations in patients\u2019 adherence to medical recommendations: a quantitative review of 50\u00a0years of research. Med Care. 2004;42:200\u20139.","journal-title":"Med Care"},{"key":"9867_CR17","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/jnci\/94.9.652","volume":"94","author":"AH Partridge","year":"2002","unstructured":"Partridge AH, Avorn J, Wang PS, Winer EP. Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst. 2002;94:652\u201361.","journal-title":"J Natl Cancer Inst"},{"key":"9867_CR18","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1200\/JCO.2009.26.3087","volume":"28","author":"D Marin","year":"2010","unstructured":"Marin D, Bazeos A, Mahon FX, Eliasson L, Milojkovic D, Bua M, et al. Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib. J Clin Oncol. 2010;28:2381\u20138.","journal-title":"J Clin Oncol"},{"key":"9867_CR19","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.1182\/blood-2008-12-196543","volume":"113","author":"L Noens","year":"2009","unstructured":"Noens L, van Lierde MA, De Bock R, Verhoef G, Zachee P, Berneman Z, et al. Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study. Blood. 2009;113:5401\u201311.","journal-title":"Blood"},{"key":"9867_CR20","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2165\/00019053-200725060-00004","volume":"25","author":"T Darkow","year":"2007","unstructured":"Darkow T, Henk HJ, Thomas SK, Feng W, Baladi JF, Goldberg GA, et al. Treatment interruptions and non-adherence with imatinib and associated healthcare costs: a retrospective analysis among managed care patients with chronic myelogenous leukaemia. Pharmacoeconomics. 2007;25:481\u201396.","journal-title":"Pharmacoeconomics"},{"key":"9867_CR21","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.leukres.2010.10.017","volume":"35","author":"L Eliasson","year":"2011","unstructured":"Eliasson L, Clifford S, Barber N, Marin D. Exploring chronic myeloid leukemia patients\u2019 reasons for not adhering to the oral anticancer drug imatinib as prescribed. Leuk Res. 2011;35:626\u201330.","journal-title":"Leuk Res"},{"key":"9867_CR22","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.leukres.2012.01.021","volume":"36","author":"A Gater","year":"2012","unstructured":"Gater A, Heron L, Abetz-Webb L, Coombs J, Simmons J, Guilhot F, et al. Adherence to oral tyrosine kinase inhibitor therapies in chronic myeloid leukemia. Leuk Res. 2012;36:817\u201325.","journal-title":"Leuk Res"},{"key":"9867_CR23","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s11606-007-0180-x","volume":"22","author":"BA Briesacher","year":"2007","unstructured":"Briesacher BA, Gurwitz JH, Soumerai SB. Patients at-risk for cost-related medication nonadherence: a review of the literature. J Gen Intern Med. 2007;22:864\u201371.","journal-title":"J Gen Intern Med"},{"key":"9867_CR24","doi-asserted-by":"crossref","first-page":"553","DOI":"10.18553\/jmcp.2008.14.6.553","volume":"14","author":"J Kennedy","year":"2008","unstructured":"Kennedy J, Tuleu I, Mackay K. Unfilled prescriptions of medicare beneficiaries: prevalence, reasons, and types of medicines prescribed. J Manag Care Pharm. 2008;14:553\u201360.","journal-title":"J Manag Care Pharm"},{"key":"9867_CR25","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/01.mlr.0000108742.26446.17","volume":"42","author":"JD Piette","year":"2004","unstructured":"Piette JD, Wagner TH, Potter MB, Schillinger D. Health insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of care. Med Care. 2004;42:102\u20139.","journal-title":"Med Care"},{"key":"9867_CR26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1345\/aph.1D252","volume":"38","author":"SA Vik","year":"2004","unstructured":"Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother. 2004;38:303\u201312.","journal-title":"Ann Pharmacother"},{"key":"9867_CR27","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00228-006-0246-4","volume":"63","author":"A Bardel","year":"2007","unstructured":"Bardel A, Wallander MA, Svardsudd K. Factors associated with adherence to drug therapy: a population-based study. Eur J Clin Pharmacol. 2007;63:307\u201314.","journal-title":"Eur J Clin Pharmacol"},{"key":"9867_CR28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1023\/B:PHAR.0000013464.09197.41","volume":"26","author":"A Ekedahl","year":"2004","unstructured":"Ekedahl A, Mansson N. Unclaimed prescriptions after automated prescription transmittals to pharmacies. Pharm World Sci. 2004;26:26\u201331.","journal-title":"Pharm World Sci"},{"key":"9867_CR29","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.ijnurstu.2008.07.002","volume":"45","author":"AF Williams","year":"2008","unstructured":"Williams AF, Manias E, Walker R. Adherence to multiple, prescribed medications in diabetic kidney disease: A qualitative study of consumers\u2019 and health professionals\u2019 perspectives. Int J Nurs Stud. 2008;45:1742\u201356.","journal-title":"Int J Nurs Stud"},{"key":"9867_CR30","doi-asserted-by":"crossref","first-page":"a288","DOI":"10.1136\/bmj.a288","volume":"337","author":"A Kuper","year":"2008","unstructured":"Kuper A, Reeves S, Levinson W. An introduction to reading and appraising qualitative research. BMJ. 2008;337:a288.","journal-title":"BMJ"},{"key":"9867_CR31","first-page":"253","volume":"6","author":"N Macdonald","year":"2012","unstructured":"Macdonald N, Shapiro A, Bender C, Paolantonio M, Coombs J. Experiences and perspectives on the GIST patient journey. Patient Prefer Adherence. 2012;6:253\u201362.","journal-title":"Patient Prefer Adherence"},{"key":"9867_CR32","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/bmj.320.7227.114","volume":"320","author":"C Pope","year":"2000","unstructured":"Pope C, Ziebland S, Mays N. Qualitative research in health care. Analysing qualitative data. BMJ. 2000;320:114\u20136.","journal-title":"BMJ"},{"key":"9867_CR33","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/cncr.23427","volume":"112","author":"E Jabbour","year":"2008","unstructured":"Jabbour E, Cortes JE, Kantarjian HM. Molecular monitoring in chronic myeloid leukemia: response to tyrosine kinase inhibitors and prognostic implications. Cancer. 2008;112:2112\u20138.","journal-title":"Cancer"},{"key":"9867_CR34","first-page":"18","volume":"17","author":"MR DiMatteo","year":"2004","unstructured":"DiMatteo MR. Evidence-based strategies to foster adherence and improve patient outcomes. JAAPA. 2004;17:18\u201321.","journal-title":"JAAPA"},{"key":"9867_CR35","doi-asserted-by":"crossref","first-page":"984","DOI":"10.6004\/jnccn.2009.0065","volume":"7","author":"S O\u2019Brien","year":"2009","unstructured":"O\u2019Brien S, Berman E, Borghaei H, Deangelo DJ, Devetten MP, Devine S, et al. NCCN clinical practice guidelines in oncology: chronic myelogenous leukemia. J Natl Compr Canc Netw. 2009;7:984\u20131023.","journal-title":"J Natl Compr Canc Netw"},{"key":"9867_CR36","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.suponc.2011.08.001","volume":"10","author":"M Cornelison","year":"2012","unstructured":"Cornelison M, Jabbour EJ, Welch MA. Managing side effects of tyrosine kinase inhibitor therapy to optimize adherence in patients with chronic myeloid leukemia: the role of the midlevel practitioner. J Support Oncol. 2012;10:14\u201324.","journal-title":"J Support Oncol"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-013-9867-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-013-9867-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-013-9867-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T06:16:34Z","timestamp":1646892994000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-013-9867-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,24]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["9867"],"URL":"https:\/\/doi.org\/10.1007\/s11096-013-9867-8","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,24]]}}}